A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03435081 · COMPLETED
Trial details
- NCT number
- NCT03435081
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-12-09
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.